参考文献/References:
[1] 魏社鹏，赵继宗. 脑干胶质瘤[J]. 国际神经病学神经外科学杂志，2008，13（3）：231-235.
[2] 阴鲁鑫，张力伟，李德志. 儿童脑干胶质瘤[J]. 中国医刊，2010，45（2）：28-30.
[3] 张俊平. 儿童脑干胶质瘤化疗的研究进展[J]. 中华神经外科杂志，2017，33（5）：520-523.
[4] Long W, Yi Y, Chen S, et al. Potential new therapies forpediatric diffuse intrinsic pontine glioma [J]. Front Pharma-col, 2017, 8: 495.
[5] Hashizume R. Epigenetic targeted therapy for diffuse intrin-sic pontine glioma [J]. Neurol Med Chir (Tokyo), 2017, 57(7): 331-342.
[6] Lapin DH, Tsoli M, Ziegler DS. Genomic insights into dif-fuse intrinsic pontine glioma [J]. Front Oncol, 2017, 7: 57.
[7] Kaye EC, Baker J N, Broniscer A. Management of diffuseintrinsic pontine glioma in children: current and future strategies for improving prognosis [J]. CNS Oncol, 2014, 3(6): 421-431.
[8] Vallero SG, Bertin D, Basso ME, et al. Diffuse intrinsicpontine glioma in children and adolescents: a single-center experience [J]. Childs Nerv Syst, 2014, 30(6): 1061-1066.
[9] Panditharatna E, Yaeger K, Kilburn LB, et al. Clinicopatho-logy of diffuse intrinsic pontine glioma and its redefined genomic and epigenomic landscape [J]. Cancer Genet, 2015,208(7-8): 367-373.
[10] Veldhuijzen VZS, Jansen MH, Sanchez AE, et al. A twenty-year review of diagnosing and treating children with diffuse intrinsic pontine glioma in The Netherlands [J]. Expert Rev Anticancer Ther, 2015, 15(2): 157-164.
[11] Pierre-Aurelien B, Alexandru S, Federico DR, et al. Diffuse intrinsic pontine glioma in children: document or treat [J]?World Neurosurg, 2016, 93: 411-485.
[12] Lober RM, Cho YJ, Tang Y, et al. Diffusion-weighted MRI derived apparent diffusion coefficient identifies prognosti-cally distinct subgroups of pediatric diffuse intrinsic pontineglioma [J]. J Neurooncol, 2014, 117(1): 175-182.
[13] Puget S, Blauwblomme T, Grill J. Is biopsy safe in children with newly diagnosed diffuse intrinsic pontine glioma [J]?Am Soc Clin Oncol Educ Book, 2012, 2012: 629-633.
[14] Hamisch C, Kickingereder P, Fischer M, et al. Update on the diagnostic value and safety of stereotactic biopsy for pediatric brainstem tumors: a systematic review and meta-analysis of 735 cases [J]. J Neurosurg Pediatr, 2017, 20(3):261-268.
[15] Buczkowicz P, Hawkins C. Pathology, molecular genetics, and epigenetics of diffuse intrinsic pontine glioma [J]. Front Oncol, 2015, 5: 147.
[16] Buczkowicz P, Bartels U, Bouffet E, et al. Histopathological spectrum of paediatric diffuse intrinsic pontine glioma: diagnostic and therapeutic implications [J]. Acta Neuropa-thol, 2014, 128(4): 573-581.
[17] Schwartzentruber J, Korshunov A, Liu XY, et al. Drivermutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma [J]. Nature, 2012, 482(7384):226-231.
[18] Wu G, Diaz AK, Paugh BS, et al. The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brain-stem high-grade glioma [J]. Nat Genet, 2014, 46(5): 444-450
[19] Fontebasso AM, Papillon-Cavanagh S, Schwartzentruber J, et al. Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma [J]. Nat Genet, 2014, 46(5):462-466.
[20] Misuraca KL, Cordero FJ, Becher OJ. Pre-clinical models of diffuse intrinsic pontine glioma [J]. Front Oncol, 2015, 5:172
[21] Cohen KJ, Heideman RL, Zhou T, et al. Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology Group [J]. Neuro Oncol, 2011, 13(4): 410-416.
[22] Frappaz D, Schell M, Thiesse P, et al. Preradiation chemo-therapy may improve survival in pediatric diffuse intrinsic brainstem gliomas: final results of BSG 98 prospective trial[J]. Neuro Oncol, 2008, 10(4): 599-607.
[23] Bailey S, Howman A, Wheatley K, et al. Diffuse intrinsic pontine glioma treated with prolonged temozolomide and radiotherapy--results of a United Kingdom phase II trial (CNS 2007 04) [J]. Eur J Cancer, 2013, 49(18): 3856-3862.
[24] 权俊杰，周 乐，付海燕，等. 替莫唑胺化疗联合放疗对弥漫性内生型脑干胶质瘤临床疗效及预后分析[J]. 临床和实验医学杂志，2015，14（4）：310-313.
[25] Zaghloul MS, Eldebawy E, Ahmed S, et al. Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pon-tine glioma (DIPG): a randomized controlled trial [J]. Radiother Oncol, 2014, 111(1): 35-40.
[26] Gokce-Samar Z, Beuriat PA, Faure-Conter C, et al. Pre-radiation chemotherapy improves survival in pediatric diffuse intrinsic pontine gliomas [J]. Childs Nerv Syst, 2016,32(8): 1415-1423.
[27] Freeman CR, Kepner J, Kun LE, et al. A detrimental effect of a combined chemotherapy-radiotherapy approach in children with diffuse intrinsic brain stem gliomas [J]. Int J Radiat Oncol Biol Phys, 2000, 47(3): 561-564.
[28] Scutti J. Importance of immune monitoring approaches and the use of immune checkpoints for the treatment of diffuse intrinsic pontine glioma: From bench to clinic and vice versa [J]. Int J Oncol, 2018, 52(4): 1041-1056.
[29] Fried I, Lossos A, Ben AT, et al. Preliminary results ofimmune modulating antibody MDV9300 (pidilizumab) treatment in children with diffuse intrinsic pontine glioma[J]. J Neurooncol, 2018, 136(1): 189-195.
相似文献/References:
[1]周建华 胡 涛 陈 宇 雷 丹 陈谦学.lncRNA NEAT1在人脑胶质瘤的表达变化及其与病人预后的关系[J].中国临床神经外科杂志,2019,(03):148.[doi:10.13798/j.issn.1009-153X.2019.03.007]
ZHOU Jian- hua,HU Tao,CHEN Yu,et al.Relationship of expression level of long non-coding RNA NEAT1 with prognoses in the patients with gliomas[J].,2019,(03):148.[doi:10.13798/j.issn.1009-153X.2019.03.007]
[2]杨 智 唐 栋 曹 磊 杨光诚.血清外泌体miRNA-30a-5p在人脑胶质瘤诊断及预后评价中的作用[J].中国临床神经外科杂志,2020,(05):296.[doi:10.13798/j.issn.1009-153X.2020.05.013]
YANG Zhi,TANG Dong,CAO Lei,et al.Value of serum exosome miRNA-30a-5p to diagnosis and prognosis evaluation of human glioma[J].,2020,(03):296.[doi:10.13798/j.issn.1009-153X.2020.05.013]
[3]许强华 陈新军 刘平非 谢 腾 陈晓巍 陈治军.TSA联合HSV-1对C6鼠胶质瘤细胞株细胞增殖、细胞凋亡的影响[J].中国临床神经外科杂志,2020,(05):299.[doi:10.13798/j.issn.1009-153X.2020.05.014]
XU Qiang-hua,CHEN Xin-jun,LIU Pin-fei,et al.Effects of TSA combined with HSV-1 on cell proliferation and apoptosis of C6 glioma cells[J].,2020,(03):299.[doi:10.13798/j.issn.1009-153X.2020.05.014]